Navani V, Meyers DE, Ruan Y, Boyne DJ, et al. Lung Immune Therapy Evaluation (LITE) Risk, a Novel Prognostic Model for Patients With Advanced Non-Small Cell Lung Cancer Treated With Immune Checkpoint Blockade. Clin Lung Cancer 2023 Jan 20:S1525-7304(23)00004.
PMID: 36774234